Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 24,122 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 24,122 | n/a |
| Jun 5, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| Mar 18, 2025 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 1,819 | $220.4K |
| May 24, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| Mar 19, 2024 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 1,678 | $247.5K |
| Mar 7, 2024 | AGILENT TECHNOLOGIES, INC. (A) | Sale | 1,658 | $239.3K |
| May 30, 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 9,000 | n/a |
| Mar 21, 2023 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 1,658 | $226.8K |
| Nov 28, 2022 | AGILENT TECHNOLOGIES, INC. (A) | Sale | 3,635 | $566.5K |
| May 27, 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 15,000 | n/a |